Research programme: Helicobacter pylori vaccine - Ainos
Latest Information Update: 07 Jan 2022
At a glance
- Originator Amarillo Biosciences; Ohio State University
- Class Bacterial vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Helicobacter infections
Most Recent Events
- 07 Nov 2006 Discontinued - Preclinical for Helicobacter infections in USA (Parenteral)
- 23 Oct 2001 Preclinical development for Helicobacter infections in USA (Parenteral)